Taligen Therapeutics Inc. closed a tranched Series B financing round that eventually could bring the company as much as $65 million. Woodruff Emlen, co-founder, president and CEO of Aurora, ...
Shanghai Meiyue Biotech Development Co. Ltd. has synthesized spiro compounds acting as complement factor B (CFB) inhibitors reported to be useful for the treatment of age-related macular degeneration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results